Work

MiR-93 Attenuates CALR Mutant-Driven Oncogenic Activity in Myeloproliferative Neoplasms

Year: 2026
Type: article
Abstract: High Mobility Group AT-hook 2 (HMGA2), a recognized oncogene in myeloproliferative neoplasm (MPN), is regulated by dozens of microRNAs (miRNAs), notably, let-7a. We hypothesize that other miRNAs might influence HMGA2-associated phenotypic characteristics in MPN, as well. To explore further, we applied a miRNA library screening system to identify potential HMGA2 mRNA 3′-untranslated region (3′UTR)-targeting candidates and evaluated their functional effects in MPN cell models. MicroRNA-93 (miR-93) was among the few HMGA2 3′UTR-targeting miRNAs differentially expressed in MPN cells, being downregulated in CALR-mutated cells but not in JAK2V617F-mutated cells. Correspondingly, HMGA2 overexpression was observed in CALR-mutated cells. Luciferase reporter assays confirmed that miR-93 could target a highly conserved sequence within the HMGA2 3′UTR region. Upregulation of miR-93 in CALR-mutated cells significantly impeded cellular growth and increased apoptosis in vitro. Rapid development of myelofibrosis phenotypes was observed in immune-deficient mice transplanted with CALR-mutated cells. Ectopic expression of miR-93 in these cells attenuated myelofibrosis-like phenotypes in vivo and prolonged the survival of these mice. Clinically, higher miR-93 expression was associated with features suggesting a more indolent disease course in a small cohort of CALR-mutated MPN patients, although these observations were exploratory. Collectively, our experimental findings support a potential tumor-suppressive role for miR-93 in CALR-mutated MPN, while the clinical associations require further validation in larger patient cohorts.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236828064
FWCI:
Cites: 49
Cited by:
Related to: 10